
SR15006
CAS No. 2505001-54-5
SR15006( —— )
Catalog No. M28507 CAS No. 2505001-54-5
SR15006 is Krüppel-like factor 5 (KLF5) inhibitor (IC50 = 41.6 nM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 31 | Get Quote |
![]() ![]() |
5MG | 50 | Get Quote |
![]() ![]() |
10MG | 87 | Get Quote |
![]() ![]() |
25MG | 178 | Get Quote |
![]() ![]() |
50MG | 335 | Get Quote |
![]() ![]() |
100MG | 500 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameSR15006
-
NoteResearch use only, not for human use.
-
Brief DescriptionSR15006 is Krüppel-like factor 5 (KLF5) inhibitor (IC50 = 41.6 nM).
-
DescriptionSR15006 is Krüppel-like factor 5 (KLF5) inhibitor (IC50 = 41.6 nM).(In Vitro):In DLD-1 CRC cells, SR15006 (1 μM or 10 μM) causes a significant reduction in the levels of tested cyclins over the course of 72 hours.
-
In VitroSR15006 (1 μM or 10 μM; DLD-1 CRC cells) causes a significant reduction in the levels of tested cyclins over the course of 72 hours.
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2505001-54-5
-
Formula Weight385.87
-
Molecular FormulaC16H20ClN3O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (259.15 mM)
-
SMILESO=C(C=CC=1C=CC=C(Cl)C1)NCC(=O)N2CCN(CC2)S(=O)(=O)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
DHX9-IN-2
DHX9-IN-2 is an inhibitor targeting ATP-dependent RNA de-helicase A (DHX9) with anticancer and antitumor activity for cancer research.
-
HALOFUGINONE LACTATE
HALOFUGINONE LACTATE is a halogenated derivative of febrifugine, a natural quinazolinone-containing compound found in the Chinese herb D. febrifuga.Halofuginone inhibits prolyl-tRNA synthetase in an ATP-dependent manner with a Ki of 18.3 nM.?Halofuginone is a specific inhibitor of type-I collagen synthesis and attenuates osteoarthritis (OA) by inhibition of TGF-β activityhalofuginone (HF), a widely studied derivative of febrifugine, inhibits the development of T(H)17-driven autoimmunity in a mouse model of multiple sclerosis by activating the amino acid response (AAR) pathway.?HF binds glutamyl-prolyl-tRNA synthetase (EPRS), inhibiting prolyl-tRNA synthetase activity;?this inhibition is reversed by the addition of exogenous proline or EPRS.
-
DTP3 TFA
DTP3 TFA is a potent and selective GADD45β/MKK7 (growth arrest and DNA-damage-inducible β/mitogen-activated protein kinase kinase 7) inhibitor. DTP3 (10 μM; 1-21 days) causes the potent and tumor-selective induction of JNK activation and apoptosis.